Stonepine Capital Management’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.8K Sell
40,000
-62,367
-61% -$112K 0.08% 80
2025
Q4
$167K Buy
+102,367
New +$158K 0.13% 61
2022
Q4
Sell
-1,540,671
Closed -$2.83M 23
2022
Q3
$2.83M Sell
1,540,671
-1,947,257
-56% -$4.07M 1.27% 15
2022
Q2
$7.5M Sell
3,487,928
-730,141
-17% -$1.76M 3.49% 13
2022
Q1
$13.2M Buy
4,218,069
+211,884
+5% +$667K 5.49% 5
2021
Q4
$12.9M Buy
4,006,185
+753,293
+23% +$2.58M 5.9% 5
2021
Q3
$10.9M Buy
3,252,892
+1,252,892
+63% +$4.57M 4.97% 5
2021
Q2
$7.82M Sell
2,000,000
-483,059
-19% -$1.91M 4.09% 7
2021
Q1
$9.98M Buy
+2,483,059
New +$8.25M 5.39% 6

Other funds holding OVID